ANGELA YOUNG: Open Payments
NPI 1295196210 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 32 payments from 16 companies in 2025. Trend: 2023 $214 · 2024 $1,560 · 2025 $1,697
Food & beverage: $1,697
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 4 | $398 |
| Amgen Inc. | 4 | $262 |
| CVRx, Inc. | 3 | $208 |
| SCPHARMACEUTICALS INC. | 3 | $172 |
| Boston Scientific Corporation | 1 | $133 |
| Gilead Sciences, Inc. | 1 | $130 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $63 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| Novo Nordisk Inc | 2 | $40 |
Products named: Assure WCD, REPATHA, Barostim Neo System, FUROSCIX, General - Therapies, Livdelzi, LEQVIO, LifeVest.
Industry payments across FL — which companies pay providers there.
